中国医院
中國醫院
중국의원
CHINESE HOSPITALS
2014年
3期
20-22
,共3页
医药科技%技术创新%成果转化
醫藥科技%技術創新%成果轉化
의약과기%기술창신%성과전화
medical technology%technology innovation%technology transfer
目的:了解上海市医药科技成果转化现状及存在的问题,并提出相应建议。方法运用文献评阅、现场调研和专家咨询等方法来分析上海市医学科技成果转化的现状。结果:上海市医药科技成果转化存在的问题:相关法律制度尚未健全,促进医药技术创新的政策支持不够;科研人员转化意识不强,有市场潜力的成果比例低;医疗机构当前投入不足以有效管理科研成果;转化医学从研究到转化的发展路径不够通畅;配套的分配和激励机制不完善;资金投入不足,转化中试环节薄弱;政府宏观管理下的科技中介服务体系亟待完善。结论:推进上海市医药科技成果转化的政策建议:加强法律和制度建设;完善卫生技术转移服务网络,加强政府对转化医学发展的宏观指导,建立健全的激励机制。
目的:瞭解上海市醫藥科技成果轉化現狀及存在的問題,併提齣相應建議。方法運用文獻評閱、現場調研和專傢咨詢等方法來分析上海市醫學科技成果轉化的現狀。結果:上海市醫藥科技成果轉化存在的問題:相關法律製度尚未健全,促進醫藥技術創新的政策支持不夠;科研人員轉化意識不彊,有市場潛力的成果比例低;醫療機構噹前投入不足以有效管理科研成果;轉化醫學從研究到轉化的髮展路徑不夠通暢;配套的分配和激勵機製不完善;資金投入不足,轉化中試環節薄弱;政府宏觀管理下的科技中介服務體繫亟待完善。結論:推進上海市醫藥科技成果轉化的政策建議:加彊法律和製度建設;完善衛生技術轉移服務網絡,加彊政府對轉化醫學髮展的宏觀指導,建立健全的激勵機製。
목적:료해상해시의약과기성과전화현상급존재적문제,병제출상응건의。방법운용문헌평열、현장조연화전가자순등방법래분석상해시의학과기성과전화적현상。결과:상해시의약과기성과전화존재적문제:상관법률제도상미건전,촉진의약기술창신적정책지지불구;과연인원전화의식불강,유시장잠력적성과비례저;의료궤구당전투입불족이유효관이과연성과;전화의학종연구도전화적발전로경불구통창;배투적분배화격려궤제불완선;자금투입불족,전화중시배절박약;정부굉관관리하적과기중개복무체계극대완선。결론:추진상해시의약과기성과전화적정책건의:가강법률화제도건설;완선위생기술전이복무망락,가강정부대전화의학발전적굉관지도,건립건전적격려궤제。
Objectives:To understand the problems of medical technology transfer and its suggestions for the current situation in Shanghai. Methods:The methods of literature review, investigation and Delphi expert consulting methods are used for analyzing the problems of medical technology transfer within the current situation in Shanghai. Results:Problems in medical technolofy transfer can be described as related legal system has not completely established. The policy to support medical technology innovation is stil not strong enough. There has weak conscious in researches’ mind to complete medical technology transfer, which results in low rate of commercialization of high market potential patents. Because of the insuf icient input from medical institutions, the management of scientific achievements is under the low level. The development path of translational medicine is not smooth. Distribution and incentive mechanism reflect imperfection. The investments are shortage, and pilot plant test of medical technology transfer are poor. The system of scientific and technological intermediary control ed by government should be improved. Conclusion:Enhance the establishment of law system. Improve the network of medical technology transfer service. Stimulate the support of macro-directions from the government to develop the translational medicine. Incentive mechanism needs to be seamless remolded.